These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


215 related items for PubMed ID: 28350758

  • 1. Effects of ultralow topical estriol dose on vaginal health and quality of life in postmenopausal women who underwent surgical treatment for pelvic organ prolapse.
    Caruso S, Cianci S, Vitale SG, Matarazzo MG, Amore FF, Cianci A.
    Menopause; 2017 Aug; 24(8):900-907. PubMed ID: 28350758
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ultralow 0.03 mg vaginal estriol in postmenopausal women who underwent surgical treatment for stress urinary incontinence: effects on quality of life and sexual function.
    Caruso S, Cianci A, Sarpietro G, Matarazzo MG, Panella M, Cianci S.
    Menopause; 2020 Feb; 27(2):162-169. PubMed ID: 31834156
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
    Alvisi S, Lami A, Baldassarre M, Lenzi J, Mancini I, Seracchioli R, Meriggiola MC.
    J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
    [Abstract] [Full Text] [Related]

  • 10. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women.
    Cruz VL, Steiner ML, Pompei LM, Strufaldi R, Fonseca FLA, Santiago LHS, Wajsfeld T, Fernandes CE.
    Menopause; 2018 Jan; 25(1):21-28. PubMed ID: 28763401
    [Abstract] [Full Text] [Related]

  • 11. A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive.
    Serati M, Bogani G, Di Dedda MC, Braghiroli A, Uccella S, Cromi A, Ghezzi F.
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():48-50. PubMed ID: 26070127
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
    Fernandes T, Costa-Paiva LH, Pedro AO, Baccaro LF, Pinto-Neto AM.
    Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study.
    Garcia de Arriba S, Grüntkemeier L, Häuser M, May TW, Masur C, Stute P.
    PLoS One; 2022 Jul; 17(5):e0266633. PubMed ID: 35551533
    [Abstract] [Full Text] [Related]

  • 15. Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial.
    Diem SJ, Guthrie KA, Mitchell CM, Reed SD, Larson JC, Ensrud KE, LaCroix AZ.
    Menopause; 2018 Oct; 25(10):1086-1093. PubMed ID: 29738424
    [Abstract] [Full Text] [Related]

  • 16. Monurelle Biogel® vaginal gel in the treatment of vaginal dryness in postmenopausal women.
    Nappi RE, Cagnacci A, Becorpi AM, Nappi C, Paoletti AM, Busacca M, Martella S, Bellafronte M, Tredici Z, Di Carlo C, Corda V, Vignali M, Bagolan M, Sardina M.
    Climacteric; 2017 Oct; 20(5):467-475. PubMed ID: 28657769
    [Abstract] [Full Text] [Related]

  • 17. Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause?
    Matarazzo MG, Caruso S, Giunta G, Valenti G, Sarpietro G, Cianci A.
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():75-79. PubMed ID: 29367168
    [Abstract] [Full Text] [Related]

  • 18. A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting.
    Sánchez-Rovira P, Hirschberg AL, Gil-Gil M, Bermejo-De Las Heras B, Nieto-Magro C.
    Oncologist; 2020 Dec; 25(12):e1846-1854. PubMed ID: 32459035
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial.
    Chen J, Geng L, Song X, Li H, Giordan N, Liao Q.
    J Sex Med; 2013 Jun; 10(6):1575-84. PubMed ID: 23574713
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.